NKARTA INC. - COMMON STOCK

Nkarta Announces Departure of Chief Financial & Business Officer

30 مارس 2023 16:01:00 بحسب Nasdaq GlobeNewswire

Nkarta Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights

16 مارس 2023 16:01:00 بحسب Nasdaq GlobeNewswire

Nkarta to Participate at Upcoming Investor Conferences

09 فبراير 2023 08:02:00 بحسب Nasdaq GlobeNewswire

Nkarta Promotes David R. Shook, M.D., to Chief Medical Officer

09 يناير 2023 16:30:23 بحسب Nasdaq GlobeNewswire

Nkarta Announces Updated Clinical Data on Anti-CD19 Allogeneic CAR-NK Cell Therapy NKX019 for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

05 ديسمبر 2022 07:02:00 بحسب Nasdaq GlobeNewswire

Nkarta to Host Conference Call to Discuss Updated Clinical Data from NKX019 NK Cell Therapy Program

02 ديسمبر 2022 16:02:00 بحسب Nasdaq GlobeNewswire

Nkarta Reports Third Quarter 2022 Financial Results and Corporate Highlights

09 نوفمبر 2022 16:02:00 بحسب Nasdaq GlobeNewswire

Nkarta Presents Data Supporting Engineered NK Cell Based Combination Therapies and Next Generation Commercial-Scale Manufacturing Platform at SITC 37th Annual Meeting

07 نوفمبر 2022 08:52:47 بحسب Nasdaq GlobeNewswire

Nkarta to Participate at Upcoming Investor Conferences

02 نوفمبر 2022 08:02:00 بحسب Nasdaq GlobeNewswire

Nkarta Reports Second Quarter 2022 Financial Results and Corporate Highlights

11 أغسطس 2022 16:02:00 بحسب Nasdaq GlobeNewswire

Nkarta Announces Key Senior Leadership Team Appointments

25 يوليو 2022 16:31:00 بحسب Nasdaq GlobeNewswire

Nkarta to Participate at Upcoming Investor Conference

31 مايو 2022 07:02:00 بحسب Nasdaq GlobeNewswire

Nkarta Appoints David R. Shook, MD, as Vice President, Clinical Development

16 مايو 2022 16:02:00 بحسب Nasdaq GlobeNewswire

Nkarta Reports First Quarter 2022 Financial Results and Corporate Highlights

12 مايو 2022 16:02:00 بحسب Nasdaq GlobeNewswire

Nkarta Announces Closing of Upsized Public Offering of Common Stock and Underwriters’ Full Exercise of Option to Purchase Additional Shares

28 أبريل 2022 16:01:00 بحسب Nasdaq GlobeNewswire

Nkarta Announces Pricing of Upsized Public Offering of Common Stock

25 أبريل 2022 23:19:11 بحسب Nasdaq GlobeNewswire

Nkarta Announces Proposed Public Offering of Common Stock

25 أبريل 2022 16:01:00 بحسب Nasdaq GlobeNewswire

Nkarta Announces Positive Preliminary Dose Finding Data for Two Lead Engineered Natural Killer Cell Programs

25 أبريل 2022 07:00:00 بحسب Nasdaq GlobeNewswire

Nkarta to Host Conference Call Highlighting Preliminary Clinical Data from Two Lead NK Cell Therapy Candidates

22 أبريل 2022 16:10:00 بحسب Nasdaq GlobeNewswire

Nkarta Presents New Preclinical Data from Engineered NK Cell Platform at AACR Annual Meeting 2022

08 أبريل 2022 13:25:08 بحسب Nasdaq GlobeNewswire